Serum heat shock protein levels in patients with chronic obstructive pulmonary disease

R. Ünver, F. Deveci, G. Kirkil, D. Kaman (Elazig, Turkey)

Source: International Congress 2014 – Clinical problems in acute and chronic lung diseases
Session: Clinical problems in acute and chronic lung diseases
Session type: Thematic Poster Session
Number: 3656
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
R. Ünver, F. Deveci, G. Kirkil, D. Kaman (Elazig, Turkey). Serum heat shock protein levels in patients with chronic obstructive pulmonary disease. Eur Respir J 2014; 44: Suppl. 58, 3656

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Increased serum level of apelin in chronic obstructive pulmonary disease
Source: International Congress 2015 – COPD: interesting notes
Year: 2015


The systemic inflammation and factors of coagulation in patients with chronic obstructive pulmonary disease (COPD)
Source: International Congress 2014 – COPD markers
Year: 2014


Prediction of chronic renal failure in patients with chronic obstructive pulmonary disease
Source: International Congress 2014 – COPD: points to ponder
Year: 2014


Features of systemic inflammation in patients with stable COPD
Source: International Congress 2014 – COPD: points to ponder
Year: 2014


Can HSP27 and HSP70 be used as biomarkers for chronic obstructive pulmonary disease diagnosis?
Source: International Congress 2015 – Non-exhaled biomarkers in the assessment of airways disease
Year: 2015

Increased total serum levels of ghrelin and nesfatin in chronic obstructive pulmonary disease
Source: International Congress 2015 – Notable abstracts in exacerbations, mechanisms and biomarkers in COPD
Year: 2015


Serum angiopoietin-2 levels in stable and exacerbated chronic obstructive pulmonary disease
Source: International Congress 2015 – Cellular and molecular mechanisms of COPD and emphysema
Year: 2015


Prevalence of exacerbation in COPD patients with chronic bronchitis and association with elevated serum inflammatory biomarkers
Source: International Congress 2014 – Systemic biomarkers for airway diseases
Year: 2014


Increased heart rate modulation, sympathetic dominance and systemic inflammation in chronic obstructive pulmonary disease
Source: International Congress 2014 – Markers
Year: 2014

Dysregulation of serum miRNA in chronic obstructive pulmonary disease
Source: International Congress 2015 – Genetics, genomics and exposures in asthma and COPD
Year: 2015


Serum levels of leptin and visfatin in chronic obstructive pulmonary disease
Source: International Congress 2015 – Different data in COPD
Year: 2015


Elevated circulating CTLA-4 level in patients with COPD is related to systemic inflammation and disease severity
Source: Annual Congress 2013 –COPD: markers and inflammation
Year: 2013



Analysis of the microbiota of sputum samples from patients with chronic obstructive pulmonary disease
Source: International Congress 2014 – COPD exacerbations
Year: 2014


Association between adipokines, inflammatory markers and systemic manifestations in chronic obstructive pulmonary disease (COPD) patients
Source: International Congress 2016 – Biomarkers and phenotypes of COPD and comorbidities
Year: 2016

Nutritional status in chronic obstructive pulmonary disease
Source: International Congress 2014 – Comorbidities
Year: 2014


Peculiarities of intracardiac hemodynamics in patients with chronic obstructive pulmonary disease
Source: International Congress 2014 – Clinical presentations
Year: 2014


Influence of systemic inflammation and hypoxaemia on bone metabolism in patients with chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2013 –COPD diagnosis
Year: 2013


Age-dependent systemic elastin degradation is enhanced in chronic obstructive pulmonary disease
Source: International Congress 2016 – New signalling pathways in COPD
Year: 2016


Comparison of blood eosinophils and plasma periostin in stable and non-stable chronic obstructive pulmonary disease: How we can improve the management of our patients
Source: International Congress 2016 – Biomarkers and phenotypes of COPD
Year: 2016


Cardiac troponin T levels increase overnight in patients with stable chronic obstructive pulmonary disease
Source: Annual Congress 2013 –The vulnerable patient and ageing cells
Year: 2013